Cargando…
REgistry-based randomized controlled trial of treatment and Duration and mortality in long-term OXygen therapy (REDOX) study protocol
OBJECTIVE: Long-term oxygen therapy (LTOT) during 15 h/day or more prolongs survival in patients with chronic obstructive pulmonary disease (COPD) and severe hypoxemia. No randomized controlled trial has evaluated the net effects (benefits or harms) from LTOT 24 h/day compared with 15 h/day or the e...
Autores principales: | Sundh, Josefin, Bornefalk-Hermansson, Anna, Ahmadi, Zainab, Blomberg, Anders, Janson, Christer, Currow, David C., McDonald, Christine F., McCaffrey, Nikki, Ekström, Magnus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390558/ https://www.ncbi.nlm.nih.gov/pubmed/30808321 http://dx.doi.org/10.1186/s12890-019-0809-7 |
Ejemplares similares
-
Agreement of the modified Medical Research Council and New York Heart Association scales for assessing the impact of self-rated breathlessness in cardiopulmonary disease
por: Ahmadi, Zainab, et al.
Publicado: (2022) -
Long-Term Oxygen Therapy 24 vs 15 h/day and Mortality in Chronic Obstructive Pulmonary Disease
por: Ahmadi, Zainab, et al.
Publicado: (2016) -
Validation of the Swedish Multidimensional Dyspnea Profile (MDP) in outpatients with cardiorespiratory disease
por: Ekström, Magnus, et al.
Publicado: (2019) -
Clinical validation of the Swedish version of Dyspnoea-12 instrument in outpatients with cardiorespiratory disease
por: Sundh, Josefin, et al.
Publicado: (2019) -
Daily duration of long-term oxygen therapy and risk of hospitalization in oxygen-dependent COPD patients
por: Sundh, Josefin, et al.
Publicado: (2018)